Professional Documents
Culture Documents
Lachman, Leon. 1994. Teori dan Praktek Farmasi Industri Edisi III. UI-Press;Jakarta.
Brunton LL, Lazo JS, Parker KL. (2006). Goodman and Gilman’s The Pharmacological
Basis of Therapeutics. Eleventh edition. McGrawHill. New York.
Dukes, M., & Meyler, L. (1975). Meyler's side effects of drugs. Amsterdam: Excerpta Medica.
Hitner H, Nagle B. (2012). Pharmacology An Introduction. Sixth Edition. McGraw Hill. New
York.
Pasaribu, M., Tandirogang, N., Ismail, S., Paramita, S., Magdaleni, A., & Nugroho, H. (2017).
Potensi Ekstrak Etanol Rimpang Jeringau (Acorus Calamus L.) sebagai Spasmolitik. Jurnal
Sains dan Kesehatan, 1(7), 338-339.
Fusi, F., Manetti, F., Durante, M., Sgaragli, G., Saponara,S.(2015). The vasodilator papaverine
stimulates L-type Ca2+ current in rat tail artery myocytes via a PKA-dependent mechanism.
Vascular Pharmacology, 76, 53-54.
Reynolds JEF. Martindale The Extra Pharmacopeia. 28th edition. London: The Pharmaceutical
Press; 1982.
Medidata. (2016). MIMS Petunjuk Konsultasi Edisi 16 Tahun 2016/2017 (15th ed.). Jakarta:
Bhuana Ilmu Populer.
MIMS. http://mims.com/indonesia/drug/info/papaverine/?type=brief&mtype=generic
Papaverine Uses, Side Effects & Warnings - Drugs.com. (2020). Retrieved 12 October 2020,
from https://www.drugs.com/mtm/papaverine.html
Papaverine (Injection Route) Proper Use - Mayo Clinic. (2020). Retrieved 11 October 2020,
from https://www.mayoclinic.org/drugs-supplements/papaverine-injection-route/proper-use/drg-
20065314
Papaverine (Oral Route) Proper Use - Mayo Clinic. (2020). Retrieved 11 October 2020, from
https://www.mayoclinic.org/drugs-supplements/papaverine-oral-route/proper-use/drg-20065323
Papaverine Side Effects: Common, Severe, Long Term - Drugs.com. (2020). Retrieved 12
October 2020, from https://www.drugs.com/sfx/papaverine-side-effects.html
Papaverine hydrochloride. (2019). Retrieved 12 October 2020, from
https://pubchem.ncbi.nlm.nih.gov/compound/6084#section=Computed-Descriptors
McVary, K. (2007). Erectile Dysfunction. New England Journal Of Medicine, 357(24), 2472-
2481.
Leem, Y., Park, J., Park, J., Kim, D., Kang, J., & Kim, H. (2020). Papaverine inhibits α-
synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3
expression in the subacute MPTP/P mouse model of Parkinson’s disease. Biomedicine &
Pharmacotherapy, 130, 110576. doi: 10.1016/j.biopha.2020.110576
Wen, M., El-Kamel, A., & Khalil, S. (2011). Systemic enhancement of papaverine transdermal
gel for erectile dysfunction. Drug Development And Industrial Pharmacy, 38(8), 915.
Heghes, S., Vostinaru, O., Rus, L., Mogosan, C., Iuga, C., & Filip, L. (2019). Antispasmodic
Effect of Essential Oils and Their Constituents: A Review. Molecules, 24(9), 3-4.